BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 18391764)

  • 1. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic selective neck dissection: a 25-year review.
    Muzaffar K
    Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
    Dagan R; Morris CG; Kirwan JM; Werning JW; Vaysberg M; Amdur RJ; Mendenhall WM
    Laryngoscope; 2010 May; 120(5):945-52. PubMed ID: 20422688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
    Koo BS; Lim YC; Lee JS; Choi EC
    Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
    Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
    Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
    Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma.
    Maulard C; Housset M; Brunel P; Huart J; Ucla L; Rozec C; Delanian S; Baillet F
    Laryngoscope; 1992 Aug; 102(8):884-90. PubMed ID: 1495353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of extracapsular lymph node spread in the ipsilateral neck on contralateral neck metastasis and prognosis of laryngeal cancer].
    Liu B; Guan C; Ji WY; Pan ZM
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):871-5. PubMed ID: 17416015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and impact of lymph node metastases in oropharyngeal cancer.
    Shimizu K; Inoue H; Saitoh M; Ohtsuki N; Ishida H; Makino K; Amatsu M; Nibu K
    Acta Otolaryngol; 2006 Aug; 126(8):872-7. PubMed ID: 16846932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.